Related by context. All words. (Click for frequent words.) 79 Study ETDRS 70 ETDRS 65 Visual acuity 61 Brief Psychiatric 60 virological response 60 BCVA 60 Depressive Symptoms 60 Prostate Biopsy 60 Angiographic 59 Negative Syndrome 59 State Examination MMSE 59 Montgomery Asberg Depression 59 multivariate Cox 59 Adverse Outcomes 59 Metastatic Renal Cell Carcinoma 59 Rating Scale MADRS 59 Index CDAI 58 ETDRS eye chart 58 Viral Suppression 58 ADAS cog 58 retest reliability 58 Clinical Outcome 58 STRATEGY FOR AN OPEN 58 sham injections 58 Inventory BPI 58 Detecting Breast Cancer 57 Subgroup Analysis 57 aldosterone antagonist 57 Functional Outcomes 57 STRIDE PD 57 Randomized Clinical Trial 57 Histologic 57 DAS# scores 57 Randomized Controlled Trials 57 #F FDG PET CT 57 FDG-PET/CT 57 JAK Inhibitor 57 ARB telmisartan 57 Univariate 57 Crohn Disease Activity 57 Solid Tumors 56 Treatment Outcome 56 Lowering Blood Pressure 56 Response Evaluation Criteria 56 Carotid Stenting 56 Cardiotoxicity 56 Unstable Angina Patients Suppress 56 Histopathologic 56 Prognostic Value 56 logistic regression 56 Statistically Significant 56 Primary endpoints 56 relapsed MM 56 Multicenter Phase 56 Prognostic Significance 56 Risk Stratification 56 prospective multicentre 56 Coronary Artery Calcium 56 Negative Symptoms 56 Decitabine 56 Medication Adherence 56 EBMT criteria 56 Clinical Trial Results 56 Pharmacokinetic parameters 56 TNSS 56 Neuropsychological Status 55 Distress Scale 55 Septic Shock 55 Wechsler Adult 55 Scale PANSS 55 MDRD 55 posttest 55 Randomized Trials 55 YMRS 55 ADHD RS 55 Physical Function 55 Rheumatoid Arthritis Patients 55 Fracture Risk 55 -#.# log# copies mL 55 Long Term Outcomes 55 Renal Function 55 Alzheimer Disease Assessment 55 Lupus Drug 55 Visual Analog Scale 55 By RohitSharma TennisEarth.com 55 calculated creatinine clearance 55 Demonstrated Significant 55 Solid Tumors RECIST 55 Chronic Illness Therapy 55 ADCS CGIC 55 Repeatable Battery 55 Non Responders 55 NYHA functional class 55 Logistic Regression 55 Cognitive Function 55 Treating Chronic 55 Protein Structures 55 Colorectal Cancer Patients 55 FDG PET scans 55 UPDRS 55 Main Outcome Measures 55 mTSS 55 Selective Cardiac Myosin 55 Lipid Levels 55 trough FEV1 55 HAM D# 55 Inflammatory Pain 55 Cholinesterase Inhibitors 55 mean ± SEM 55 Total Knee Arthroplasty 54 interobserver 54 QIDS SR 54 Optical Coherence Tomography 54 Nicotine Vaccine 54 EQ 5D 54 -#.# log# 54 Subtypes 54 Genetic Variants 54 HCV SPRINT 54 Histological 54 Invasive Breast Cancer 54 Neuropsychiatric Inventory NPI 54 Antipsychotic Drug 54 Localized Prostate Cancer 54 Dose Escalation 54 Platelet Function 54 Outpatient Setting 54 morphometric vertebral fractures 54 convergent validity 54 By AjayTyagi TennisEarth.com 54 Visual Analogue Scale VAS 54 Brain Metastases 54 Reproducible 54 Prospective Randomized 54 Left Ventricular 54 Montgomery Åsberg Depression 54 undetectable HBV DNA 54 Confirmatory Phase 54 Descriptive statistics 54 Vertebral Fracture 54 RECIST Response Evaluation Criteria 54 viral kinetics 54 CONSORT 54 PANSS Positive 54 By KushalSharma TennisEarth.com 54 Venous Thromboembolism 54 QTcF 54 Solid Tumors criteria 54 Diagnostic Criteria 54 posttreatment 54 HOMA IR 54 Genetic Tests 54 generalized estimating 54 multicenter multinational 54 Severity Index PASI 54 Cronbach alpha 54 MADRS score 54 Functional Capacity 54 CNS LS 54 mg BID dose 54 Hemoglobin A1c 54 Abnormal Involuntary Movement 54 depressive symptom 54 Pain Intensity 54 Viral Load 54 Antidepressant Treatment 54 Initiated Phase 54 Radiation Dose 54 Antibiotic Treatment 54 Opioid Use 54 IBDQ 54 Investigational Agent 54 Geriatric Depression 54 postoperative radiographs 54 Estrogen Therapy 54 Myocardial Infarction 54 unpaired t 53 International Prostate Symptom 53 Clinician Administered PTSD 53 Colorectal Screening 53 Major Averages Remain Firmly 53 Pfizer reanalyzed 53 fluorodeoxyglucose positron emission tomography 53 serum aminotransferase levels 53 logistic regression analyzes 53 Negative Symptom Scale 53 interrater reliability 53 placebo controlled dose escalation 53 interrater 53 moderate renal impairment 53 Coronary Revascularization 53 Treating Depression 53 Tumor Response 53 semiquantitative 53 PANSS 53 PASI scores 53 Visual Acuity 53 Carotid Artery Stenting 53 Guideline Update 53 Cytogenetic 53 Global Impression CGI 53 Myocardial Ischemia 53 ADHD Rating Scale 53 fasting plasma glucose FPG 53 EMBLEM TM 53 Outcome Measures 53 Brief Pain 53 Kidney Function 53 Rating Scale BPRS 53 Predict Dementia 53 SCr 53 Symptom Checklist 53 Randomized Evaluation 53 oxycodone CR 53 Kidney Transplants 53 Sustained virologic response 53 Scale EDSS 53 Data Suggest 53 HAQ DI 53 Immune Responses 53 EDSS score 53 Inhaled Nitric Oxide 53 Health Assessment Questionnaire 53 conditional logistic regression 53 serum phosphorous 53 Prognostic Factors 53 Hematological Cancers 53 By KarenWalker TennisEarth.com 53 Genetic Mutations 53 serum clusterin levels 53 Phase 2a Trial 53 Relapsing Remitting Multiple Sclerosis 53 Pain Rating Scale 53 ADAS Cog 53 Androgen Deprivation 53 Renal Tumors 53 Diagnostic Tools 53 retrospective observational study 53 Echocardiographic 53 LOCF 53 postintervention 53 Predict Prostate Cancer 52 Pulmonary Vein Isolation 52 alanine aminotransferase ALT 52 exploratory endpoints 52 Quality Indicators 52 Sleep Disturbance 52 Multiple Myeloma Patients 52 Predictive Value 52 Noncritical 52 Flesch Reading 52 multivariable analysis 52 Multicenter Trial 52 Myocardial Perfusion 52 Disease Severity 52 Mini Mental 52 Patients Receiving 52 Fibromyalgia Impact Questionnaire 52 Mantel Haenszel 52 Neoadjuvant Chemotherapy 52 Pearson correlation coefficient 52 Clinical Trial Data 52 Detect Cancer 52 Cardiac Function 52 Mammographic 52 FOR AN OPEN 52 Track Scanning Radiometer 52 interobserver reliability 52 Gastrointestinal Stromal Tumors 52 Disease Activity 52 DAS# CRP 52 logistic regression models 52 Combination Clinical Trial 52 Scale Cognitive Subscale 52 Comorbidities 52 Ocular Surface Disease 52 multivariable Cox 52 ANOVA 52 HDRS 52 plain radiographs 52 Grading Scale 52 Meta analyzes 52 gadolinium enhancing lesions 52 Expanded Disability Status 52 MMSE 52 Phase 2b Study 52 WOMAC TM 52 Genetic Defect 52 prospectively stratified 52 secondary efficacy endpoint 52 Prognostic 52 Bonferroni 52 Watchful Waiting 52 sUA 52 Systematic Review 52 Loss Severity 52 estimated glomerular filtration 52 serum HBV DNA 52 NIHSS 52 Aggressive Prostate Cancer 52 mL/min/#.# m 2 52 multivariate logistic regression 52 preintervention 52 Lymph Nodes 52 serum urate 52 HER2 expression 52 Secondary efficacy endpoints 52 Respiratory Symptoms 52 ANCOVA 52 psychometric properties 52 NAMCS 52 Scale cognitive subscale 52 NWEA MAP 52 randomized multicenter 52 Intraocular Pressure 52 Stem Cell Transplants 52 Interrater reliability 52 Randomized Clinical Trials 52 statistical significance p 52 Visual Analog 52 Clinical Outcomes 52 Combo Therapy 52 Pearson correlation coefficients 52 Imaging Techniques 52 Randomised 52 antibody titer 52 Successful Implementation 52 meta regression 52 NIH CPSI 52 Wilcoxon rank sum 52 estimated GFR 52 genotypic resistance 52 Lung Cancer Trial 52 Gene Variation 52 aspartate aminotransferase AST 52 NLSY 52 Stable Angina 52 Score IPSS 52 mRS 52 Data Extraction 52 myocardial viability 52 Main Outcome Measure 52 multiple logistic regression 52 Inhaled Corticosteroids 52 urine albumin 52 intraobserver 52 Edinburgh Postnatal Depression 52 Antiretroviral Therapy 52 Relieve Depression 52 definite stent thrombosis 52 Natural Catastrophe Stress 51 Kaplan Meier analysis 51 Platelet counts 51 HAMD 51 Clinical Guideline 51 Study Shows Benefits 51 HAM D 51 PHQ 9 51 pretest probability 51 Laryngeal Cancer 51 Spectrum Pharmaceuticals Announces 51 Million Cribs Recalled 51 prospectively defined 51 Lung Cancer Vaccine 51 Dose Reduction 51 Brain Scans 51 non menstrual pelvic 51 Transplant Patients 51 Tasigna prolongs 51 corticosteroid dose 51 See CLINICAL PHARMACOLOGY 51 Mortality Risk 51 Test Methodology 51 WAIS III 51 Symptom severity 51 plasma pharmacokinetics 51 Gene Mutation 51 APACHE II 51 Significant Efficacy 51 PANSS total 51 prognostic variables 51 Y BOCS 51 SF #v# 51 Therapeutic Efficacy 51 By GokulPillai TennisEarth.com 51 multivariate analyzes 51 Kaydon Corporation Announces 51 dimensional echocardiography 51 Diabetic Retinopathy 51 Sociodemographic 51 Radiation Exposure 51 Acute Physiology 51 http:/www.ncbi.nlm.nih.gov/pubmed/# 51 Psoriasis Area 51 NSQIP 51 Poisson regression 51 Bloodstream Infections 51 Anti Clotting Drug 51 ADHD Medication 51 CHADS2 51 Significantly Improved 51 Training Effectiveness 51 CR nPR 51 Pharmacodynamic 51 lumbar spine BMD 51 GAMMAGARD 51 Neuropsychiatric Inventory 51 SELENA SLEDAI 51 Last Observation Carried 51 subtests 51 Repeatability 51 HADS 51 Wechsler Memory 51 electrophysiologic 51 Breast Carcinoma 51 Pre Cancerous 51 Epidemiologic Follow 51 Technological Advances 51 Index CDAI score 51 RAPAFLO R 51 Premature Infants 51 Effective Treatments 51 hematologic parameters 51 Capacity FVC 51 Uncorrected 51 urinary N telopeptide 51 Nation Spending Habits 51 Breast Density 51 randomized controlled trials RCTs 51 Lymphoma Patients 51 x ULN 51 Rating Scale IRLS 51 clinico pathological 51 glycated hemoglobin 51 Hamilton Rating Scale 51 histopathologic 51 demonstrated clinically meaningful 51 Diagnostic Tests 51 #F FDG PET 51 Cardiac Marker 51 Lung Transplants 51 Mania Rating Scale 51 PSA nadir 51 CDAI score 51 postop 51 symptom severity 51 subthreshold depression 51 subanalysis 51 binary logistic regression 51 Sleep Duration 51 hemoglobin A1c HbA1c 51 HRQL 51 indicates cardio circulatory 51 Menstrual Pain 51 OGTT 51 MMSE score 51 Clinical Practice Guideline 51 MERIT ES 51 multicentre randomized 51 apolipoprotein B 51 Rating Scale UPDRS 51 enzyme immunoassay EIA 51 Breast Tumors 51 Grouped Hockey 51 lactate dehydrogenase LDH 51 UACR 51 Ramco Gershenson Announces 51 Timed Walk 51 Patients Suffering 51 Prospective Multicenter 51 Radiofrequency Ablation 51 Coronary Arteries 50 cytologic 50 Home Buyer Seller 50 -Patney 50 4mg/kg 50 Dollar Sags 50 Ebola Vaccine 50 covariance ANCOVA 50 Breast Cancer Genes 50 Lesion 50 Mad Cow Testing 50 Percutaneous Coronary Interventions 50 Showed Significant 50 chi squared 50 Likert pain 50 Arterial Hypertension 50 Survival Rates 50 Unified Parkinson Disease 50 colonoscopy flexible sigmoidoscopy 50 AirBoss Announces 50 Cholesterol Lowering Drugs 50 Observational Studies 50 multiple linear regression 50 WME ranking 50 sensitivity specificity 50 Treat Heart Failure 50 Clinical Significance 50 meta analytic 50 Sustained Efficacy 50 PTH analog 50 Kaplan Meier method 50 serum cortisol 50 logistic regressions 50 univariate 50 PERMP 50 Predictors 50 XPEL Announces 50 Surgical Procedures 50 Urinary Catheter 50 Insulin Therapy 50 Seattle Angina Questionnaire 50 fasting plasma glucose 50 glycosylated hemoglobin levels 50 Phenotypic 50 efficacy evaluable 50 intravascular ultrasonography 50 Digital Mammographic Imaging 50 Vertebral Fractures 50 Serologic 50 PCI ExTRACT TIMI 50 CDAI 50 Strongly Linked 50 Smallpox Vaccination 50 Urogenital Distress Inventory 50 prospective observational cohort 50 multicenter randomized controlled 50 methotrexate monotherapy 50 MMSE scores 50 Randomized Study 50 logMAR 50 intima media thickness IMT 50 Protein Expression 50 epoetin alpha 50 postoperative complication 50 subscore 50 creatinine clearance 50 prespecified 50 variography 50 retrospective cohort 50 specific antigen PSA 50 Abdominal Fat 50 NIHSS score 50 BMI z 50 Blood Pressure Drugs 50 Ambulatory EHR ensures 50 PSQI 50 bivariate 50 Heart Transplant Recipients 50 prespecified secondary 50 hydroxy vitamin D 50 AUA Symptom Score 50 Vitamin D Supplementation 50 Clinical Relevance 50 Coronary Calcium 50 DSM IV SCID 50 AVI BioPharma Announces 50 Study Evaluates 50 Bone Marrow Cells 50 MS DRG 50 Abciximab 50 Suicidal Ideation 50 HbA1c levels 50 tapentadol ER 50 logistic regression analysis 50 Cardiogenic Shock 50 Nord Trøndelag Health 50 EHR Adoption 50 periprocedural 50 Elevated Levels 50 glomerular filtration rate 50 Reveals Significant 50 Kruskal Wallis test 50 Blocked Arteries 50 randomisation 50 virologic 50 Helps Predict 50 HbA 1c 50 Brain Wiring 50 glycosylated hemoglobin HbA1c 50 sustained virologic response 50 differential gene expression 50 Harsh Interrogation 50 CI -#.# 50 Functional Assessment 50 HSCT 50 Multicore Processor 50 Enzyme Linked 50 IPSS 50 Reperfusion 50 SSRI SNRI 50 CORE OM 50 pairwise comparisons 50 Gentium Announces 50 salivary cortisol 50 EuroIntervention 50 Bonferroni correction 50 Intervention Trial 50 Sensitivity specificity 50 LUX Lung 50 Genetic Variation 50 SPIRIT FIRST 50 Ventricular Arrhythmias 50 Thrombus 50 glycated hemoglobin HbA1c 49 Gender Differences 49 Flesch Kincaid 49 COBIT Control 49 Ishak fibrosis score 49 Diamyd Medical Diamyd 49 Cystic Fibrosis Questionnaire Revised 49 Menopausal Hormone Therapy 49 Community Acquired Pneumonia 49 florbetaben 49 HIV RNA 49 subscores 49 overt nephropathy 49 erythrocyte sedimentation rate 49 Prostate Cancer Diagnosis 49 Imaging Technique 49 receiving concomitant corticosteroids 49 Gene Variants 49 Effectiveness Data 49 Causing Bacteria 49 Cognitive Problems 49 BY TriCities.com Staff 49 Airborne Geophysical 49 Eye Diseases 49 variance ANOVA 49 CPAP adherence 49 genomewide 49 Kaplan Meier survival 49 psychopathological symptoms 49 serum PSA 49 www.thelancet.com 49 hemoglobin A1c levels 49 Secondary Endpoints 49 Mathematics Teaching 49 MADRS 49 nasal symptom 49 scintigraphic 49 Likert Scale 49 Home Hemodialysis 49 Results Indicate 49 confirmed CCyR 49 retinal thickness 49 GASB Issues 49 NMIBC 49 Sirolimus Eluting Stent 49 Unmet Medical 49 Aortic Dissection 49 Cardiovascular Outcomes 49 stepwise logistic regression 49 PCWP 49 Pluripotent Stem Cells 49 undetectable HCV RNA 49 Results Confirm 49 albumin excretion rate 49 Accelrys Announces 49 Hamilton Anxiety Scale 49 biochemical relapse 49 Antibiotic Use 49 AVERROES 49 Schizophrenia Treatment 49 Lower Limb 49 Blood Pressure Monitoring 49 Fasting Glucose 49 lateral radiographs 49 Prostate Cancer Risk 49 Statin Drugs 49 cardiac magnetic resonance 49 dactylitis 49 hours postdose 49 Primary Endpoint 49 Assigns LS 49 actigraphy 49 Regression Analysis 49 Screening Trial DMIST 49 NHAMCS 49 Cardiopulmonary bypass 49 Treatment Outcomes 49 SABESP Announces 49 Solid Tumours 49 correlation coefficients 49 Inhaled Steroids 49 univariate analyzes 49 creatinine clearance CrCl 49 Systolic Blood Pressure 49 % Confidence Interval 49 Continued Listing Requirements 49 RECIST criteria 49 male Wistar rats 49 #mg/day [001] 49 echocardiographic parameters 49 Aortic Stenosis 49 DLQI 49 Operative mortality 49 -#.# mg dL [002] 49 Endothelial function 49 AST ALT 49 Mutational 49 PSADT 49 Cognitive Abilities Test 49 pharmacodynamic parameters 49 IQR 49 Artificial Cornea 49 JAPAN SOCIETY 49 Chronic Obstructive Lung 49 Analytical Method 49 Whole Genome Sequencing 49 Doppler echocardiography 49 Logistic regression 49 logistic regression model 49 intravascular hemolysis 49 Global Impression 49 Scale EDSS score 49 NTIOL 49 HBV DNA levels 49 ACR# [002] 49 pain subscale 49 Genotypic 49 Premature Birth 49 Kaplan Meier estimates 49 REFLEX 49 Organ Rejection 49 ADCS ADL 49 log# copies mL 49 Clin Trials 49 Biologic Drugs 49 Glucose Monitoring 49 NFL.com Wire 49 Pivotal Trials 49 Non Invasive Treatment 49 3rd edn 49 symptomatic VTE 49 Multivariate 49 DAS# remission 49 allele frequencies 49 subtest 49 Cardiovascular Disease Risk 49 Anxiety Depression 49 spirometric 49 preoperative intraoperative 49 preoperative PSA 49 thyroglobulin 49 inhalation anthrax infection 49 angiography intravascular ultrasound IVUS 49 WOMAC 49 Diagnosis Treatment 49 Novel Therapeutic 48 ProfitSource 48 Conflict Tactics 48 Epithelial Cell 48 CCHIT Certification 48 plasma cortisol 48 Gravimetric finish 48 Resubmission 48 SGRQ 48 Tumor Markers 48 odds ratios ORs 48 Tumor Cells 48 multivariate regression analysis 48 Quantifiable 48 Patient Populations 48 protease inhibitor mutations 48 overnight polysomnography 48 Skin Cells 48 efficacy endpoint 48 colorimetric 48 subscale scores 48 ICD9 48 EORTC QLQ C# 48 Metabolomic 48 hemoglobin A1C 48 SF #v# R 48 Randomized phase 48 Ischaemic 48 Gene Mutations 48 NHANES III 48 OBOP showed 48 Confirmatory 48 BERTL BEST 48 Reading Fluency 48 Simulations Plus Reports 48 digit dialing RDD 48 postprocedure 48 Further Validates 48 APOE genotype 48 clinically meaningful improvement 48 microalbuminuria 48 HORIZONS AMI trial 48 Blood Pressure Medication 48 Lung Function 48 Content Outline 48 Acne Scars 48 Technological Breakthroughs 48 multivariable logistic regression 48 Genotype 48 histologic subtype 48 hematopoietic cancers 48 Multivariate logistic regression 48 liver biopsies 48 biopsy Gleason 48 Appraised Value 48 Preoperatively 48 Subsets 48 Physical Exams 48 Prolongs Life 48 hemoglobin A1c 48 Smooth Muscle 48 Tomographic 48 Carbon Nanotube Based 48 Kidney Transplantation 48 Breast Tissue 48 Mathematical Reasoning 48 Thyroid Hormone 48 univariate analysis 48 thyrotropin levels 48 leukocyte count 48 Medicure Announces 48 Targets Identified 48 Titration 48 ordinary Kriging 48 WOMAC pain 48 Fecal Incontinence 48 warfarin dosage 48 Coronary calcium 48 mean baseline A1C 48 macroalbuminuria 48 creatinine ratio 48 Could Detect 48 Baseline characteristics 48 Screening Tool 48 glomerular filtration 48 histopathological 48 Assessment Scale 48 SSAO 48 spontaneous bowel movements 48 CCyR 48 hit Philliou aorta 48 Likert type 48 HealthGrades analyzed 48 baseline FEV 48 Secondary endpoints included 48 SAXS 48 Better Outcomes 48 eNO 48 HbA 1c levels 48 variogram 48 #S rRNA gene 48 colleague Sana Inoue 48 Universal Flu Vaccine 48 Photometric 48 hsCRP levels 48 Ischemic 48 Readers Viewpoints 48 Randomized Placebo Controlled Trial 48 Tweet Sentiments web 48 Artificial Pancreas 48 sociodemographic characteristics 48 Liver Toxicity 48 Depression Inventory BDI 48 label multicenter Phase 48 anthropometric measurements 48 umol L 48 Hormonal Therapy 48 Drug Reactions 48 DAS# [002] 48 postoperative morbidity 48 inferential statistics 48 plasma HCV RNA 48 Kaplan Meier curve 48 CFQ R 48 Cell Adhesion 48 Meta Analyses 48 secondary efficacy endpoints 48 interobserver agreement 48 Regimens 48 Inductance 48 Hb A1C 48 called elastography distinguished 48 maximal treadmill 48 TAXUS ARRIVE 48 Depression Inventory 48 Cardiorespiratory fitness 48 Malaria Vaccine 48 Introductory teaser rates 48 metabolic parameters 48 symptom checklist 48 BILAG 48 seismograph stations recorded 48 Object Recognition 48 CHADS 48 Early Diagnosis 48 Heat Dissipation 48 glycated hemoglobin levels 48 Certification Criteria 48 Dollar Holds Steady 48 Counterparty Criteria 48 microbiologic 48 Genes Linked 47 generalized linear 47 de Tlahuitoltepec rural 47 Thin Film Solar Cells 47 Scattered Storms 47 Horses previewed 47 covariate 47 Study Analyzes 47 EMR Adoption 47 Inverse Distance 47 Rotavirus Vaccines 47 Pneumonia Vaccine 47 docetaxel pretreated 47 Score DAS# 47 bone bruise Bettis 47 Highly Accurate 47 fasting insulin 47 mGluR5 inhibitors 47 Institute CMM Capability 47 Prostate specific antigen 47 Prostate Cancer Cells 47 Significant Milestones 47 Discrepancy 47 multivariate statistical 47 Chronic Lyme Disease 47 Archives Journals 47 Genes Influence 47 Osteoarthritis Pain 47 microbiologically evaluable 47 WBTW Staff 47 PDL BioPharma Announces 47 fructosamine 47 CrCl 47 Progenitor Cells 47 Rubrics 47 prospective longitudinal 47 Circadian Clock 47 Ozone Levels 47 HIV HCV coinfected 47 PennyStockBets.com employees 47 Targeted Therapy 47 DCCT 47 UPDRS motor 47 EDEMA3 trial 47 vocabulary comprehension 47 HF ACTION 47 treat NNT 47 Reinspection 47 intramuscular dose 47 SIMPADICO 47 Anthropometric 47 Companion Diagnostic 47 Induction Chemotherapy 47 Supplementary Table 47 Key Milestones 47 biochemical recurrence 47 Revised Guidance 47 Likert 47 IKDC 47 Outcomes Study 47 serum ferritin 47 TIMP 1 47 Minimally Invasive Treatment 47 erection hardness 47 NNT = 47 Proves Successful 47 Highly Qualified Teacher 47 HIV tropism 47 Cognitive Deficits 47 multivariable adjusted 47 Antibiotic Therapy 47 CHMP Opinion 47 Understanding Universal BCAR 47 Underscore Need 47 Erik Ostensoe P. Geo 47 Child Behavior Checklist 47 Postmarketing 47 Achieves CMMI Level 47 Neural Networks 47 Analytical Methods 47 albumin creatinine ratio 47 corneal staining 47 ordinary differential equations 47 Kellgren Lawrence 47 Autoimmune Disorders 47 Proxy Proposals 47 Magnetic Nanoparticles 47 aminotransferase levels 47 Dementia Diagnosis 47 CSBM 47 Sexual Satisfaction 47 Novel Technique 47 maximal dose 47 #S rRNA 47 Abnormal Uterine Bleeding 47 variograms 47 Efficacy endpoints 47 Genetic Mutation 47 Winner Notification